Last10K.com

Item 9 Labs Corp. (INLB) SEC Filing 10-K Annual report for the fiscal year ending Wednesday, September 30, 2020

Item 9 Labs Corp.

CIK: 1500123 Ticker: INLB
Document and Entity Information - USD ($)
12 Months Ended
Sep. 30, 2020
Jan. 06, 2021
Mar. 31, 2020
Cover [Abstract]   
Document Type10-K  
Amendment Flagfalse  
Document Period End DateSep. 30, 2020  
Current Fiscal Year End Date--09-30  
Entity File Number000-54730  
Entity Registrant NameItem 9 Labs Corp.  
Entity Central Index Key0001500123  
Entity Incorporation, State or Country CodeDE  
Entity Well-known Seasoned IssuerNo  
Entity Voluntary FilersNo  
Entity Current Reporting StatusYes  
Entity Interactive Data CurrentYes  
Entity Filer CategoryNon-accelerated Filer  
Entity Small Businesstrue  
Entity Emerging Growth Companyfalse  
Entity Shell Companyfalse  
Entity Public Float  $ 24,660,909
Entity Common Stock, Shares Outstanding 62,715,348 
Document Fiscal Period FocusFY  
Document Fiscal Year Focus2020  

View differences made from one year to another to evaluate Item 9 Labs Corp.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Item 9 Labs Corp..

Continue

Assess how Item 9 Labs Corp.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Item 9 Labs Corp.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Changes In Stockholders' Equity
Consolidated Statements Of Operations
Acquisitions
Acquisitions (Details Narrative)
Acquisitions (Tables)
Acquisitions - Future Amortization (Details)
Acquisitions??- Identifiable Intangible Assets (Details)
Commitments And Contingencies
Commitments And Contingencies (Details Narrative)
Concentrations
Going Concern
Income Taxes
Income Taxes (Tables)
Income Taxes - Deferred Tax Assets (Details)
Income Taxes - Effective Income Tax Rate Reconciliation (Details)
Income Taxes - Income Tax Provision Computed On Taxable Income Since Reverse Merger (Details)
Income Taxes - Schedule Of Net Operating Loss Carryforward Expirations (Details)
Leases
Leases (Details Narrative)
Leases (Tables)
Leases - Future Minimum Payments Required Under Lease (Details)
Long Term Debt
Long Term Debt (Tables)
Long Term Debt - Long Term Debt (Details)
Long Term Debt - Minimum Future Payments Of All Debt Obligations (Details)
Long Term Debt - Summary Of All Interest Expense (Details)
Notes Receivable
Notes Receivable (Details Narrative)
Property And Equipment, Net
Property And Equipment, Net (Details Narrative)
Property And Equipment, Net (Tables)
Property And Equipment, Net - Summary Of Property And Equipment (Details)
Related Party Transactions
Related Party Transactions (Details Narrative)
Sale Of Airware Assets And Investment In Health Defense Llc
Sale Of Airware Assets And Investment In Health Defense Llc (Details Narrative)
Short Term Note Payable
Short Term Note Payable (Details Narrative)
Short Term Note Payable (Tables)
Short Term Note Payable - Short Term Notes Payable (Details)
Stockholders' Equity
Stockholders' Equity (Details Narrative)
Stockholders' Equity (Tables)
Stockholders' Equity - Assumptions Used For Determining Fair Value Of Options Granted (Details)
Stockholders' Equity - Fair Value Of Options Vested (Details)
Stockholders' Equity - Summary Of Stock Option Activity (Details)
Stockholders' Equity - Warrants Outstanding (Details)
Subsequent Events
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details Narrative)
Summary Of Significant Accounting Policies (Policies)
Unsecured Convertible Note Payable
Unsecured Convertible Note Payable (Details Narrative)
Variable Interest Entity

Material Contracts, Statements, Certifications & more

Item 9 Labs Corp. provided additional information to their SEC Filing as exhibits

Ticker: INLB
CIK: 1500123
Form Type: 10-K Annual Report
Accession Number: 0001554795-21-000008
Submitted to the SEC: Tue Jan 12 2021 4:15:38 PM EST
Accepted by the SEC: Tue Jan 12 2021
Period: Wednesday, September 30, 2020
Industry: Dental Equipment And Supplies

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/inlb/0001554795-21-000008.htm